Week 6 Flashcards
Hypercholesterolaemia and AD
- May increase risk for AD but no causal relationship established* Cholesterol does not enter the brain so uncertainty of link
Coronary artery disease and AD
- CAD is associated with an increased risk of dementia in general but there are overlapping risk factors for both
A decline in skills is NOT a normal part of aging
- verbal fluency,* logical analysis,* selective attention,* object naming,* complex visuospatial skills
types of dementia
- Alzheimer’s disease,
- Diffuse Lewy body dementia,
- Frontotemporal dementia (FTD)
- Posterior Corticoid Atrophy (PCA)
- Progressive primary aphasia (PPA)
- Young-onset Alzheimer’s disease (YOAD)
- Vascular dementia
How does the health care team determine the degree of cognitive impairment?
- Neuropsychological testing in the major domains of thinking and memory, verbal and expressive abilities, constructional skills, and executive functions.* Can the patient continue to handle his or her own finances, to drive, or to perform instrumental activities of daily living?
Types of rare dementias
Posterior cortical atrophy (PCA): mainly affecting visual and spatial perception
* Frontotemporal dementia (FTD): mainly affects behaviour, personality and language
* Familial AD: inherited – similar symptoms to late onset AD but can occur as young as 30
* Primary progressive aphasia (PPA): predominately affects language skills
* Lewy body dementia: Closely related to Parkinson’s Disease affecting movement and can cause hallucinations. May present with PCA
* Young onset dementias (typically YOAD and FTD)
common cognitive assessment tools
General Practitioner Assessment of Cognition (GPCOG),* Memory Impairment Screen,* Mini-Cog, Mini-Mental State Examination (MMSE),* 7-Minute Screen,* Clinical Dementia Rating,* Global Deterioration Scale,* Brief Cognitive Rating Scale,* MOCA- Montreal Cognitive Assessment* CAM
What neuroanatomic changes are seen in persons with AD?
destruction of the proteins of nerve cells of the cerebral cortex by diffuse infiltration with neurofibrillary tangles and plaques
death of nerve cells within the brain
Length of time it takes for AD to fully disable someone
3-15 years
Time of onset to death
3-20 years, avg is 8
What is Donezepil?
Donepezil is indicated for the symptomatic treatment of mild to moderate Alzheimer’s disease. Donepezil may compensate for the loss of functioning cholinergic brain cells
Can help with namely functional ability, behavior, and cognition
There is limited and conflicting evidence that long-term donepezil treatment delays time to institutionalization. There is some evidence that donepezil may be cost-effective, especially when unpaid caregiver costs are considered
Diffuse Lewy body dementia,
second most common type of dementia, characterized by the buildup of proteins into masses known as Lewy bodies. This protein also is associated with Parkinson’s disease, typically effects those over 60,
Posterior Corticoid Atrophy (PCA)
Posterior cortical atrophy is a brain and nervous system syndrome that causes brain cells to die over time. It causes problems with eyesight and with processing visual information. Common symptoms include trouble reading, judging distances and reaching for objects
Frontotemporal dementia (FTD)
In frontotemporal dementia, portions of these lobes shrink (atrophy). Signs and symptoms vary, depending on which part of the brain is affected. Some people with frontotemporal dementia have dramatic changes in their personalities and become socially inappropriate, impulsive or emotionally indifferent, while others lose the ability to use language properly, Frontotemporal dementia often begins between the ages of 40 and 65 but occurs later in life as well
Progressive primary aphasia (PPA)
Symptoms begin gradually, often before age 65. They get worse over time. People with primary progressive aphasia can lose the ability to speak and write. Eventually they’re not able to understand written or spoken language